Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aquestive Therapeutics Inc (AQST)

Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

AQST : 4.44 (-2.84%)
Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics: Q3 Earnings Snapshot

AQST : 4.44 (-2.84%)
Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

AQST : 4.44 (-2.84%)
Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylmâ„¢ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American...

AQST : 4.44 (-2.84%)
Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylmâ„¢ (epinephrine) Sublingual Film

AQST : 4.44 (-2.84%)
Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET

AQST : 4.44 (-2.84%)
3 'Strong Buy' Penny Stocks to Grab Now for More Gains

Investing in penny stocks offers the potential for substantial returns over time, but it's a high-stakes endeavor best suited for bold investors who are willing to embrace the risks.

AQST : 4.44 (-2.84%)
$SPX : 5,870.62 (-1.32%)
WULF : 7.18 (+3.38%)
^BTCUSD : 91,316.21 (-0.41%)
PL : 2.93 (-2.33%)
GOOGL : 172.49 (-1.76%)
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...

LEXX : 2.01 (-5.19%)
BIOV.CN : 0.0700 (unch)
BVAXF : 0.0494 (-1.20%)
TFFP : 0.3761 (-76.49%)
DNTH : 23.36 (-8.36%)
AQST : 4.44 (-2.84%)
Aquestive Therapeutics: Q2 Earnings Snapshot

Aquestive Therapeutics: Q2 Earnings Snapshot

AQST : 4.44 (-2.84%)
Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics: Q1 Earnings Snapshot

AQST : 4.44 (-2.84%)

Barchart Exclusives

3 Oversold Dividend Aristocrats Ready To Explode in 2025
These three companies all have one thing in common: they are all on sale. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar